Michigan Biosciences Industry Association Logo

Advocacy

Stay informed on advocacy efforts driving growth and innovation in the bio-industry. This category features updates, initiatives, and insights focused on promoting policies and actions that support our thriving community.

Advocacy Advocacy : Federal Advocacy Advocacy : State Advocacy Association Updates Event Event : Industry Event Event : MichBio Advocacy Events Event : MichBio Networking Event Event : MichBio Signature Event Event : MichBio Webinar Event : Partner Event Member Feature News News : Industry News News : Member News News : MichBio News/Statement News : Michigan News
Trump Administration Issues EO Invoking a Most Favored Nation (MFN) Drug Pricing Policy
Posted In: Federal Advocacy,
Date posted May 21

In the ongoing debate over soaring prescription drug costs in the United States, one policy proposal has gained significant attention: the...

Read Post
MichBio Joins in Opposition to Proposed Changes to MCPA
Posted In: State Advocacy,
Date posted May 9

Recent changes to Michigan's consumer protection laws have sparked debate, and a coalition of Michigan industry groups have joined to oppose the...

Read Post
MichBio Meets with Legislators Regarding Proposed 340B Legislation
Posted In: State Advocacy,
Date posted May 9

Michigan’s legislature is considering two bills, SB 94 and SB 95 related to the federal 340B Drug Pricing Program and both bills are...

Read Post
Citizen Petition Filed Against FDA's Call for Animal Testing Alternatives
Posted In: Federal Advocacy,
Date posted May 9

A citizen petition has been filed objecting to the FDA's recent call for alternatives to animal testing, arguing that it could lead to reliance on...

Read Post
NIH Issues Rules Banning DEI Activities
Posted In: Federal Advocacy,
Date posted Apr 24

The National Institutes of Health (NIH) has implemented new grant policies that prohibit funding for researchers and institutions engaged in...

Read Post
Prohibition of Pathogen Gain of Function Legislation Re-Introduced
Posted In: State Advocacy,
Date posted Apr 24

Two bills, HB 4332 and HB 4333 were recently re-introduced that would prohibit pathogen gain-of-function (GoF) research. Given that the...

Read Post
Reports Document FDA Review Delays: What It Means for Drug Manufacturers
Posted In: Federal Advocacy,
Date posted Apr 24

Recent reports have highlighted growing concerns over delays in the U.S. Food and Drug Administration's (FDA) drug review processes, particularly...

Read Post
Amid Proposed Cuts, Commission Calls For $15B NIH Support
Posted In: Federal Advocacy,
Date posted Apr 11

A federal commission, in a new report, is calling for $15 billion in new financing to reinforce the United States’ biotech leadership amid...

Read Post
Pause in Tariff Implementation Welcomed by Medtech Sector
Posted In: Federal Advocacy,
Date posted Apr 11

AdvaMed, a national medical device trade organization, of which MichBio is a state affiliate, applauded in a press release, the Trump...

Read Post
New Report on Where NIH Funding Cuts Would Hit Hardest
Posted In: Federal Advocacy,
Date posted Apr 11

According to the Science and Community Impact Mapping Project (SCIMaP), proposed NIH funding cuts could lead to $16 billion in economic loss and...

Read Post
Michigan Life Science Organizations Visit Capitol Hill
Posted In: Federal Advocacy,
Date posted Apr 10

MichBio was back on Capitol Hill last week as part of the annual BIO Legislative Fly-In to discuss issues of paramount interest to the...

Read Post
The Critical Role of Advocacy in the Bio-Industry
Posted In: Advocacy,
Date posted Apr 10

If you read our blog post Michigan Life Science Organizations Visit Capitol Hill, you would have learned about the progress we made during our...

Read Post